|
Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
|
|
Dilatrate-SR; Isordil Tembids; Isordil Titradose; Sorbitrate Oral Tablet
|
Isosorbide Dinitrate, Tablets or Extende... Clinical Trials
- Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients
ClinicalTrials.gov Identifier: NCT00337116 - Recruiting
Unstable Angina; Myocardial Infarction
- Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
Epilepsy
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
ClinicalTrials.gov Identifier: NCT00062556 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
ClinicalTrials.gov Identifier: NCT00255528 - Completed
Hypertension
- The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
ClinicalTrials.gov Identifier: NCT00195741 - Completed
Migraine
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
ClinicalTrials.gov Identifier: NCT00071253 - Terminated
Bipolar Disorder
- Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00195767 - Completed
Bipolar I Disorder, Manic or Mixed
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting
Epilepsy
- An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00060905 - Completed
Bipolar Disorder
- Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients with Dyslipidemia: A Dose-Ranging Study - SEACOAST
ClinicalTrials.gov Identifier: NCT00082251 - Completed
Hypercholesterolemia
- An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00067262 - Completed
Bipolar Disorder
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
- Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
ClinicalTrials.gov Identifier: NCT00073164 - Completed
Schizophrenia
- Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients with Dyslipidemia (OCEANS)
ClinicalTrials.gov Identifier: NCT00080275 - Completed
Hypercholesterolemia
- A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
ClinicalTrials.gov Identifier: NCT00139854 - Completed
Anxiety
- A Safety and Effectiveness Study of Methylphenidate HCl Extended-Release Tablets in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326391 - Completed
Attention Deficit Disorder With Hyperactivity
- Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aerug
ClinicalTrials.gov Identifier: NCT00481689 - Completed
Urinary Tract Infections
- Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
ClinicalTrials.gov Identifier: NCT00334568 - Terminated
Alzheimers Disease
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
ClinicalTrials.gov Identifier: NCT00268827 - Completed
HIV-1; AIDS
- Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00343629 - Completed
Unspecified Adult Solid Tumor, Protocol Specific
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
ClinicalTrials.gov Identifier: NCT00344383 - Completed
Metrorrhagia
- A Study to Evaluate LAMICTAL Extended-release Therapy in Patients with Primary Generalized Tonic Clonic Seizures
ClinicalTrials.gov Identifier: NCT00104416 - Active, not recruiting
Tonic-Clonic Seizures; Epilepsy
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
Restless Legs Syndrome
- Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00301236 - Completed
ADHD, ADD
- The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients with Intermittent Claudication - TROPIC
ClinicalTrials.gov Identifier: NCT00071266 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
Hypercholesterolemia
- An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
Analgesia
- A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
ClinicalTrials.gov Identifier: NCT00468143 - Not yet recruiting
Attention Deficit Hyperactivity Disorder
- Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
Allergy
- Tolerability of MK0524A Versus Niacin Extended-Release
ClinicalTrials.gov Identifier: NCT00378833 - Active, not recruiting
Hypercholesterolemia; Hyperlipidemia
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
Parkinson Disease
- Effect of an Investigational Compound on Tolerability of Extended Release Niacin
ClinicalTrials.gov Identifier: NCT00376584 - Active, not recruiting
Hypercholesteremia; Hyperlipidemia
- Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
Allergy
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
Essential Hypertension
- Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
ClinicalTrials.gov Identifier: NCT00247429 - Active, not recruiting
Depressive Syndrome; Anxiety
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
Allergy
- A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
Schizophrenia; Psychotic Disorders
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
Schizophrenia
- Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
Allergy
- A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00139867 - Completed
Parkinson''s Disease
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
Chronic Pain
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
Malaria
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
Schizophrenia; Bipolar Disorder
- Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
Metabolic Syndrome
- Study of Extended Release Niacin/Laropiprant on Lipids
ClinicalTrials.gov Identifier: NCT00479388 - Recruiting
Primary Hypercholesterolemia; Mixed Dyslipidemia
- Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00139724 - Completed
Overactive bladder
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
Chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
Smoking Cessation
- Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
Bipolar Disorder
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in Subjects With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00299715 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
Cerebrovascular Accident
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
Menopause
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
- 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
Schizophrenia
- Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
Hot Flashes
- A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
HIV Infection
- Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
Schizophrenia
- Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
Pyuria; Urinary Tract Infections
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
Atherosclerosis
- Lamotrigine Extended-Release in Elderly Patients With Epilepsy
ClinicalTrials.gov Identifier: NCT00516139 - Recruiting
Epilepsy
- Improving Hispanic Retention in Antidepressant Therapy
ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
Depression; Depressive Disorder
- A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
Schizophrenia
- Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
Hypertension
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
Menopause
- Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
Pain; Cancer
- A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
Schizophrenia
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
Hepatitis C, Chronic
- Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
Agitation; Dementia
- A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
Schizophrenia
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
Affective Psychosis, Bipolar; Bipolar Disorder; Mania
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
Seasonal Allergic Rhinoconjunctivitis
- A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
Schizophrenia
- Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
ClinicalTrials.gov Identifier: NCT00000478 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
- Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
Pain; Cancer
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
Posthepatitic Cirrhosis
- Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
Chronic Lymphocytic Leukemia
- Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
ClinicalTrials.gov Identifier: NCT00035347 - Completed
Pneumonia
- Exercise vs. Extended-Release Niacin in Patients With Coronary Heart Disease and Low HDL Cholesterol: Effect on Lipid Profile and Endothelial Function
ClinicalTrials.gov Identifier: NCT00298909 - Recruiting
Coronary Disease; Hypolipoproteinemia
- Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
- An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
Low Back Pain; Pain; Osteoarthritis
- Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
ClinicalTrials.gov Identifier: NCT00264615 - Completed
Epilepsy
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
Parkinson's Disease
- Evaluation of Effectiveness and Safety of Flexible-Dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
ClinicalTrials.gov Identifier: NCT00412373 - Recruiting
Psychotic Disorder; Schizoaffective Disorder
- Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
ClinicalTrials.gov Identifier: NCT00544024 - Completed
Malaria
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
Crohn''s Disease
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
